Zhai Wenlong
Clinical trials sponsored by Zhai Wenlong, explained in plain language.
-
Can targeted chemo infusion outperform pills in biliary tract cancer?
Disease control Not yet recruitingThis trial tests two chemotherapy strategies for people who have had surgery for malignant biliary tract tumors. One group receives hepatic arterial infusion chemotherapy, where drugs are delivered directly to the liver through a catheter. The other group takes capecitabine pills…
Phase 4 • Sponsor: Zhai Wenlong • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a triple drug attack stop liver cancer from coming back?
Disease control Not yet recruitingThis trial tests whether combining three treatment approaches can reduce the chance of liver cancer returning after surgery. People who had their liver cancer completely removed but showed signs of microvascular invasion, a risk factor for recurrence, will receive chemotherapy di…
Phase 4 • Sponsor: Zhai Wenlong • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC